Clinical trials

  • Empagliflozin for Type 2 diabetes|Chronic kidney disease (eGFR 10-20 ml/min/1.73 m2)
  • CETUXIMAB for Oral squamous cell carcinoma
  • VH4524184 for HIV-1 infection
  • ACORAMIDIS for Transthyretin amyloid cardiomyopathy (ATTR-CM)
  • BENZYDAMINE HYDROCHLORIDE; 2,4 DICHLOROBENZYL ALCOHOL for Acute pharyngitis
  • Brimonidine tartrate for Taxanes-induced peripheral neuropathy|Chemotherapy-induced peripheral neuropathy
  • BLINATUMOMAB for B-cell precursor acute lymphoblastic leukaemia (relapsed/refractory) | Minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukaemia
  • HUMAN NORMAL IMMUNOGLOBULIN (IV) for B-cell acute lymphoblastic leukaemia|B-cell lymphoma|Diffuse large B-cell lymphoma|Mantle cell lymphoma|Follicular lymphoma
  • Atezolizumab for Hepatocellular carcinoma (resectable)
  • IADADEMSTAT for Sickle cell disease
  • Dexmedetomidine for Delirium
  • CINEOLE for MRSA colonisation | Methicillin-resistant Staphylococcus aureus nasal carriage